After taking a beating over a proposed Zika vaccine license from the U.S. Army, Sanofi is hitting back.
New England Compounding Center's contaminated drugs caused a fungal meningitis outbreak that killed more than 60 people.
The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…
With stellar vaccine sales for GlaxoSmithKline and Bexsero, GSK is building a $175 million plant in Germany to expand production of the meningococcal B shot.
Pharma patent challenger Kyle Bass has lost his second round at the U.S. Patent and Trademark Office in as many weeks, and this time, the win is Biogen’s.
U.S. government watchdogs plan to probe the FDA's orphan drug policies after Marathon's high-profile pricing scandal.
An add-on Parkinson’s med already available in various countries throughout Europe will soon make its way to U.S. patients.
Johnson & Johnson’s new sponsorship of “Give a Spit for Cancer” features comedian Hannibal Buress in the ongoing drive to register potential bone marrow…
In 2016, many pharma marketers embraced disease awareness and charitable causes to drive better consumer engagement across social networks, according to a new…
The fast and furious two-day Round 2 match-ups carved the pharma ad field down to 16, with disease awareness emerging as a winning theme.
The U.S. government is pumping more money into anthrax bioterror preparedness.